Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769429 · ClinicalTrials.gov registry record
Continuous Blockade of the Brachial Plexus
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 53
- Enrollment target
NCT02769429: Completed study, sponsored by University of Florida.
NCT02769429 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769429 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This study will answer the question whether there is a difference in the effects and complication rates of ultrasound guided continuous interscalene block (CISB) and nerve stimulation-guided continuous cervical paravertebral block (CCPVB). The aim of this study is to evaluate the differences in efficacy and side effects - if any.
Primary Outcome
Sensory abnormalities will be assessed by sensation of cold and dermatomes sensation.
Interventions
- DEVICE Ultrasound-guided CISB
- DEVICE nerve stimulator-guided CCPVB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-09-19 |
| Est. Completion | 2018-09-26 |
What the finished NCT02769429 record still lists
NCT02769429 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound-guided CISB is the first listed.
NCT02769429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769429 about?
NCT02769429 is a clinical study titled "Continuous Blockade of the Brachial Plexus". This study will answer the question whether there is a difference in the effects and complication rates of ultrasound guided continuous interscalene block (CISB) and nerve stimulation-guided continuous cervical paravertebral block (CCPVB). The aim of this study is to evaluate the differences in effi...
What is the current status of trial NCT02769429?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2016-09-19. Estimated completion is 2018-09-26.
What interventions are being tested in trial NCT02769429?
The interventions under investigation include: Ultrasound-guided CISB (DEVICE), nerve stimulator-guided CCPVB (DEVICE).
Who is sponsoring clinical trial NCT02769429?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI